In this cluster-randomized trial, we assigned communities in Malawi, Niger, and Tanzania to four twice-yearly mass distributions of either oral azithromycin (approximately 20 mg per kilogram of body weight) or placebo. Children 1 to 59 months of age were identified in twice-yearly censuses and were offered participation in the trial. Vital status was determined at subsequent censuses. The primary outcome was aggregate all-cause mortality; country-specific rates were assessed in prespecified subgroup analyses.
Original Source [2]
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/azithromycin-reduce-childhood-mortality-sub-saharan-africa
[2] http://www.nejm.org/doi/pdf/10.1056/NEJMoa1715474
[3] http://admin.indiaenvironmentportal.org.in/category/author/jeremy-d-keenan
[4] http://admin.indiaenvironmentportal.org.in/category/author/robin-l-bailey
[5] http://admin.indiaenvironmentportal.org.in/category/author/sheila-k-west-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/antibiotic
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malawi
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tanzania
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/research
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/niger